FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels And Blood Sugar
ABT•FDA authorizes Abbott Diabetes Care device
- FDA authorizes first wearable device that continuously monitors both ketone levels and blood sugar.
- FDA granted marketing authorization to Abbott Diabetes Care for Libre Duo 10 day through the de novo premarket review pathway.
Related News
Ryman Hospitality Properties, Inc. Announces Closing Of $700 Million Of 6.250% Senior Notes Due 2035
RHP•
Instagram head Adam Mosseri begins testimony at Meta child social media addiction trial
META•
